On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.

NPJ Precis Oncol · 2020 · PMC7666126 · PMID 33299124

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In our study, patients with progressive disease showed a trend towards a ctDNA mAF increase between T5 and T9 (Figs. 2c and 3c ); however, the increase did not reach significant levels, most likely due to the low patient number.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.